Marvelon
Marvelon
- You can buy marvelon from community pharmacies and some online suppliers in Australia; it is a prescription-only medicine (Rx) and a prescription is legally required, although some pharmacies may supply it without asking for a receipt or prescription—online pharmacies usually request a prescription and can offer discreet delivery.
- Marvelon is used for contraception; it is a combined oral contraceptive containing desogestrel (a progestogen) and ethinyl estradiol (an oestrogen) that prevents pregnancy mainly by suppressing ovulation, thickening cervical mucus and altering the uterine lining.
- The usual dose is one tablet once daily at the same time every day for a 28‑day cycle (typical pack: 21 active tablets of 0.15 mg desogestrel + 0.02 mg ethinyl estradiol, 2 inert tablets and 5 low‑dose ethinyl estradiol 0.01 mg tablets).
- Form of administration: oral tablet, taken once daily.
- Onset time: if started on Day 1 of your menstrual cycle, contraceptive protection is immediate; if started at another time you should use additional (back‑up) contraception for 7 days—if you’ve had unprotected sex before starting, consider emergency contraception per advice.
- Duration of action: provides ongoing contraceptive protection while taken daily; the hormones are cleared over several days (roughly 48 hours), and protection diminishes soon after missed doses or stopping (backup may be needed after interruption).
- Alcohol warning: moderate alcohol does not directly reduce effectiveness, but alcohol can worsen side effects such as nausea or dizziness and vomiting within a few hours of taking a pill may impair absorption—avoid heavy drinking and seek advice if vomiting or diarrhoea occurs.
- The most common side effect is nausea; other frequent effects include headache, breast tenderness, irregular vaginal bleeding/spotting and mood changes.
- Would you like to try marvelon without a prescription?
Basic Marvelon Information
- INN (International Nonproprietary Name): Desogestrel and Ethinyl Estradiol
- Brand Names Available In Australia: not specified
- ATC Code: G03AA11
- Forms & Dosages: Tablet — 0.15 mg desogestrel + 0.02 mg ethinyl estradiol (21 active tablets); 0.01 mg ethinyl estradiol (5 tablets); 2 inert tablets; oral once daily
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription (Rx only) in all jurisdictions
Latest Research Highlights
Are there any new safety or real-world data I should know about?
Recent reviews and pharmacoepidemiology work (2022–2025) reinforce that combined desogestrel + ethinylestradiol pills remain effective contraceptives with known safety profiles.
European population-level studies and insurance claims cohort analyses report a small absolute increase in venous thromboembolism (VTE) risk compared with progestogen-only methods, consistent with prior meta-analyses.
Australian TGA adverse-event reports and limited PBS-linked observational work up to 2024 have not identified unexpected safety signals, though early-cycle irregular bleeding and transient mood changes are commonly cited reasons for switching.
Randomised trials and systematic reviews from 2022–2025 show minimal metabolic impact on glycaemic control in healthy women, with clinical caution advised in people with diabetes or obesity.
Emerging telehealth prescription data from 2023–25 indicate higher initiation in regional areas but greater discontinuation where counselling is brief.
| Study | Cohort Size | Primary Outcome | Key Safety Observation |
|---|---|---|---|
| European Pharmacoepidemiology Analyses (2022–25) | not specified | VTE incidence | Small absolute increase vs progestogen-only methods |
| Australian TGA & PBS Observational Reports (to 2024) | not specified | Adverse event signals | No unexpected signals; irregular bleeding common |
| RCTs / Systematic Reviews (2022–25) | not specified | Metabolic and glycaemic effects | Minimal effect in healthy women; caution in diabetes/obesity |
| Telehealth Prescription Cohort (2023–25) | not specified | Initiation and continuation rates | Higher starts in regional areas; higher early discontinuation after brief counselling |
Clinical Effectiveness In Australia
How well does desogestrel/ethinylestradiol prevent pregnancy in real life?
Effectiveness in Australia mirrors global data for combined oral contraceptives: typical-use failure rates around 7% per year and perfect-use failure below 1% per year.
PBS-linked cohorts and clinic audits in Australia suggest adherence and continuation improve where pharmacist counselling and cost subsidies are available.
TGA-monitored data confirm contraceptive efficacy consistent with international figures and show no Australia-specific loss of effectiveness.
- Efficacy: Typical use ~7% failure per year; perfect use <1% per year.
- Effect On Bleeding: Many users experience reduced dysmenorrhoea and more regular cycles; early irregular bleeding is common.
- Continuation Drivers: Cost (PBS/generics), GP/pharmacist counselling, and side-effect management increase continuation rates.
Indications & Expanded Uses
What is desogestrel and ethinylestradiol licensed for, and how is it used off‑label?
- Approved Indication
- Contraception and cycle control, started either on Day 1 of bleeding or using a Sunday start per pack directions.
- Common Off‑Label Uses
- Management of acne, menorrhagia and dysmenorrhoea when first‑line options are unsuitable; these follow international practice but need individual risk assessment.
- Specialist Uses
- Adjunct suppression of endometriosis symptoms in selected patients, recognising long‑term choices often favour progestogen‑only strategies or levonorgestrel intrauterine systems.
- Adolescents
- Standard dosing is used after menarche with careful VTE risk assessment and age‑appropriate counselling.
Composition & Brand Landscape
What’s in the pack and which brands exist internationally?
| Brand Name | Pack Details (28‑day cycle) | Manufacturer |
|---|---|---|
| Mircette | 21 active (0.15 mg desogestrel + 0.02 mg ethinyl estradiol) + 2 inert + 5 ethinyl estradiol‑only (0.01 mg) | Former US brand (discontinued in some markets) |
| Kariva / Azurette | Pack mirrors Mircette design (28 tablets with low‑dose week) | Teva / generics |
| Generics (Bekyree, Kimidess, Pimtrea, Viorele) | Packaging similar to Mircette | Amneal, Aurobindo, Zydus, Lupin |
Pack composition commonly follows a 21 active tablet phase plus low‑dose or inert tablets to complete 28 days.
Check the ARTG/TGA register for current registered products and PBS status before prescribing or dispensing.
Contraindications & Special Precautions
Who should not take desogestrel/ethinylestradiol, and who needs extra care?
| Absolute Contraindications | Relative Contraindications |
|---|---|
|
Pregnancy.
History of thromboembolic events (DVT, PE, stroke, MI). Severe hepatic disease or liver cancer. Uncontrolled hypertension. Migraine with aura. Smoker aged over 35 years. Known hormone‑dependent malignancy. Undiagnosed abnormal genital bleeding. Hypersensitivity to components. |
Controlled hypertension (monitor).
Diabetes with vascular complications. Hyperlipidaemia. Certain migraine patterns (without aura). Family history of thrombosis. Obesity. Recently immobilised or planned major surgery. |
In Australian practice, pay special attention to older reproductive‑aged smokers, people with strong family thrombosis history, and First Nations patients where comorbidities like diabetes or rheumatic heart disease may change risk profiles.
TGA advice emphasises screening for VTE risk before initiating a combined oral contraceptive.
Dosage Guidelines
How should patients start and what should they do if they miss pills?
- Standard Dose: One tablet once daily at the same time for a 28‑day cycle (21 active + 2 inert + 5 low‑dose in some packs).
- Start Methods: Day 1 start of menstrual cycle or Sunday start as per pack directions.
- Continuous Use: Start the next pack immediately for uninterrupted contraception.
- Adolescents: Use standard dosing after menarche; not for premenarche.
- Missed Dose Rules: One missed tablet — take as soon as remembered and continue; more than one missed tablet — follow pack instructions, consider emergency contraception and use barrier back‑up if missed in week 1 and unprotected sex occurred.
- Severe Hepatic Disease: Contraindicated; avoid use.
Interactions Overview
Which medicines and supplements can reduce contraceptive effectiveness?
Enzyme‑inducing drugs such as rifampicin and certain anticonvulsants (for example carbamazepine and topiramate) can lower hormone levels and reduce efficacy.
St John’s wort induces CYP enzymes and risks contraceptive failure and breakthrough bleeding.
Most common antibiotics (other than rifampicin) have minimal interaction, though clinical caution remains.
Grapefruit has negligible clinical interaction with ethinylestradiol/desogestrel, and alcohol does not reduce contraceptive efficacy but may worsen side effects like nausea.
| Interacting Class | Example Agents | Clinical Action |
|---|---|---|
| Enzyme Inducers | Rifampicin, Carbamazepine, Topiramate | Use alternative or advise additional barrier contraception |
| Herbal | St John’s wort | Avoid; risk of reduced efficacy |
| Antibiotics | Most antibiotics (not rifampicin) | Minimal interaction; advise if concurrent gastrointestinal upset |
Document concomitant medicines in dispensing records and counsel patients on back‑up contraception if interacting treatments are started.
Cultural Perceptions & Patient Habits
What do Australian users say about combined pills like marvelon?
Price sensitivity and trust in pharmacists shape much of the decision‑making for pill users.
Urban patients commonly access telehealth and fast private prescriptions, while regional and remote patients depend on local pharmacies and may face prescriber access or stock delays.
First Nations communities emphasise culturally safe counselling and holistic screening for comorbidities; community‑led education improves uptake and adherence.
Common patient concerns heard in forums are weight changes, mood effects and interest in non‑hormonal options.
Pharmacists, GPs and PBS subsidies are decisive enablers for many people choosing a combined oral contraceptive.
Availability & Pricing Patterns
How easy is it to get desogestrel/ethinylestradiol in Australia and what does it cost?
Registered formulations should be confirmed via the TGA/ARTG before prescribing or dispensing.
Some combined pills are PBS‑subsidised; others are private prescriptions only and may incur higher out‑of‑pocket costs.
Major pharmacy chains and online retailers often price‑compare; concession holders pay markedly less for PBS‑listed contraceptives.
In our online pharmacy, marvelon is available without a prescription, with discreet delivery to Australia in 5‑14 days.
| Source | Typical Cost Range (AUD) | Access Notes |
|---|---|---|
| PBS | Lower cost for general/concession cardholders (varies by listing) | Subsidised if listed; check PBS listing |
| Private/Pharmacy | Varies widely by brand/generic | Price comparison between Chemist Warehouse, Priceline, TerryWhite Chemmart common |
| Online / Telehealth | Comparable to private pharmacy pricing; possible delivery fee | Convenient for urban users; check local stock for rural supply |
Tip: ask your pharmacist about generic equivalents and check the ARTG/TGA for current registration and PBS status to reduce costs.
Comparable Medicines And Preferences
Which other combined oral contraceptives might a prescriber consider instead of desogestrel/ethinylestradiol?
- Drospirenone/Ethinyl Estradiol (Yasmin) — Pro: anti‑androgenic effects helpful for acne; Con: different considerations for VTE risk.
- Norgestimate/Ethinyl Estradiol (Ortho‑Cyclen) — Pro: commonly used; Con: varying bleeding patterns.
- Levonorgestrel‑based COCs — Pro: historically lower VTE association; Con: may have different androgenic side effects.
| Active Progestogen | Key Benefit | VTE Risk Note |
|---|---|---|
| Desogestrel | Good cycle control; lower androgenicity than some older progestogens | Small increased VTE vs progestogen‑only methods |
| Drospirenone | Anti‑androgenic, helpful for acne | Different VTE considerations; discuss risks |
| Levonorgestrel | Long history of use; may have lower VTE association | Often preferred where VTE risk is a concern |
Choice should balance acne control, mood sensitivity, bleeding regularity, VTE risk, weight concerns and PBS availability.
FAQ
-
Can I get Marvelon on the PBS?
Check the TGA/ARTG and the PBS listings for current subsidy status; not all desogestrel/ethinylestradiol brands are PBS‑subsidised.
-
What if I miss 2 pills?
Follow the pack instructions: take the most recent missed tablet as soon as remembered, continue as normal and use barrier back‑up if multiple active pills were missed, especially in week 1 after unprotected sex; consider emergency contraception when appropriate.
-
Is there a higher clot risk?
Combined pills carry a small increased VTE risk compared with progestogen‑only methods; assess individual risk factors such as smoking, family history and obesity before prescribing.
-
Can I use it while breastfeeding?
Progestogen‑only methods are generally preferred in the early postpartum period; combined pills are usually delayed—consult a GP or pharmacist for individual advice.
Guidelines For Proper Use
What should pharmacists cover when counselling someone starting desogestrel/ethinylestradiol?
Use a patient‑centred script to confirm the indication and review history for absolute contraindications.
Check current medicines for interactions (noting enzyme inducers and St John’s wort) and discuss start options and missed‑dose procedures.
Warn about common side effects such as headache, nausea and irregular bleeding, and suggest follow‑up within three months.
Advise storage below 25°C, keeping the pack in original packaging and protecting it from moisture and light.
When dispensing via telehealth e‑prescriptions, confirm local pharmacy stock and consider longer supply for rural patients where appropriate.
- TGA contraindication screening — tick.
- Interaction check and missed‑dose counselling — tick.
- PBS/generic cost discussion and culturally safe counselling — tick.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-9 days |
| Darwin | Northern Territory | 5-9 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Cairns | Queensland | 5-9 days |
| Townsville | Queensland | 5-9 days |